More important, NR4A3 is involved in the development and progression of various tumors including the primary extraskeletal myxoid chondrosarcoma, lymphoma, acute myeloid leukemia and gastric cancer, and functions as a tumor suppressor27–31. Here, NR4A3 is linked to neoplasm.